Bolt Biotherapeutics Inc
(BOLT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Sales | 11,063 | 12,960 | 13,590 | 11,263 | 14,922 |
| Cost of Goods | 5,482 | 6,645 | 6,900 | 5,729 | 7,295 |
| Gross Profit | 5,581 | 6,315 | 6,690 | 5,534 | 7,627 |
| Operating Expenses | 2,944 | 2,714 | 3,181 | 2,945 | 2,605 |
| Operating Income | 3,119 | 4,246 | 4,409 | 3,318 | 5,317 |
| Other Income | 138 | 95 | 116 | 83 | 50 |
| Pre-tax Income | 3,257 | 4,341 | 4,525 | 3,401 | 5,367 |
| Income Tax | 1,066 | 1,337 | 1,499 | 1,121 | 1,675 |
| Net Income Continuous | 2,191 | 3,004 | 3,026 | 2,280 | 3,692 |
| Net Income Discontinuous | N/A | N/A | N/A | N/A | 418 |
| Net Income | $2,191 | $3,004 | $3,026 | $2,280 | $4,110 |
| EPS Basic Total Ops | 0.25 | 0.35 | 0.35 | 0.27 | 0.48 |
| EPS Basic Continuous Ops | 0.26 | 0.35 | 0.35 | 0.27 | 0.43 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | N/A | 0.05 |
| EPS Diluted Total Ops | 0.25 | 0.35 | 0.35 | 0.27 | 0.48 |
| EPS Diluted Continuous Ops | 0.26 | 0.35 | 0.35 | 0.27 | 0.43 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | N/A | 0.05 |
| EBITDA(a) | $3,312 | $4,443 | $4,598 | $3,505 | $5,494 |